Related Experiment Video

Updated: Aug 15, 2026

Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor
09:33

Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor

Published on: August 25, 2023

Neurofibromatosis 2 and malignant mesothelioma

M E Baser1, A De Rienzo, D Altomare

  • 1baser@earthlink.net

Neurology
|July 24, 2002
PubMed

Insights

Individuals with neurofibromatosis 2 (NF2) may have increased susceptibility to malignant mesothelioma. This study reports a case linking NF2, asbestos exposure, and mesothelioma development.

Area of Science:

  • Oncology
  • Genetics
  • Environmental Health

Background:

  • The neurofibromatosis 2 (NF2) tumor suppressor gene is linked to the inherited disorder NF2.
  • Mutations in the NF2 gene are frequently observed in malignant mesothelioma.
  • Malignant mesothelioma is not a typical characteristic of NF2.

Observation:

  • A case study of an individual with both NF2 and malignant mesothelioma, who had asbestos exposure.
  • Immunohistochemical analysis showed a loss of NF2 protein expression in the mesothelioma tissue.
  • Comparative genomic hybridization identified chromosomal abnormalities, including losses of chromosomes 14, 15, and 22, and a gain of chromosome 7.

Findings:

  • The study confirms the loss of the NF2 tumor suppressor protein in a mesothelioma case.
  • Genomic analysis reveals specific chromosomal alterations associated with the tumor.
  • The co-occurrence of NF2 and mesothelioma in an asbestos-exposed individual is documented.

Implications:

  • Individuals with a constitutional NF2 mutation may be more vulnerable to developing malignant mesothelioma.
  • This finding highlights the potential role of NF2 in mesothelioma pathogenesis, particularly in environmentally exposed populations.
  • Further research into NF2's role in mesothelioma could inform risk assessment and therapeutic strategies.

More Related Videos

Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models08:57

Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models

Published on: May 17, 2024

An Orthotopic Sciatic Nerve Xenograft for Neurofibromatosis Type 1 Neurofibromas03:53

An Orthotopic Sciatic Nerve Xenograft for Neurofibromatosis Type 1 Neurofibromas

Published on: October 10, 2025

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...